Nation’s Oldest Marijuana Reform Group Praises DEA’s Decision to Reschedule Marijuana, But Says “It Fails to Go Far Enough”

The National Organization for the Reform of Marijuana Laws (NORML), the oldest pro-marijuana reform group in the world (est 1970), has praised the DEA’s decision to reschedule marijuana, while promising to continue fighting for full legalization.

“Yesterday, the Department of Justice affirmed that the DEA has concurred with an HHS recommendation to move cannabis from Schedule I to Schedule III of the Controlled Substances Act”, says NORML Deputy Director Paul Armentano. “While the DEA’s opinion to reschedule cannabis fails to go far enough, it represents the first time the agency has ever abandoned its ‘Flat Earth’ position toward cannabis and acknowledged that the substance possesses legitimate therapeutic utility.”

Armentano says “Still, it continues to perpetuate the growing divide between federal marijuana laws and the marijuana legalization laws of a growing number of states. It also fails to align with public opinion, as most Americans agree that cannabis should be treated more like alcohol than like ketamine. Nonetheless, this decision marks both a symbolic and a very tangible victory.”

Armentano goes on to say that once enacted, “this move will provide immediate benefits to both the state-legal industry and cannabis consumers – such as providing lower prices for retail products and providing greater flexibility to who can legally consume cannabis and whereIdeally, it will also encourage lawmakers at the state and federal level to take further steps to amend and repeal cannabis criminalization.

I have personally spoken with dozens of mainstream media outlets—including The Washington Post, The New York Times, Fox News, Voice of America, The Los Angeles Times, USA Today, Reuters, Agence France-Presse, and others—regarding the implications of this change. I can tell you firsthand that pundits, influencers, and lawmakers consider this move a seismic and long-overdue shift in federal cannabis policy.”

The deputy director says that “Perhaps most tellingly, our political opponents are also touting its significance, pledging to take whatever steps necessary to derail this proposed policy change. In fact, within minutes of the DEA’s announcement, a major prohibitionist group issued a press release announcing their intent to “oppose the Attorney General’s decision in the rulemaking process and to challenge any final rescheduling decision in court. Prohibitionists are taking this stance because they know that this change may very well mark the beginning of the fall of federal cannabis prohibition.”

In the coming months, Armentano says NORML anticipates “high-profile battles over the fate of federal rescheduling. Some of these battles may take place in court, and others may take place in the halls of Congress. And even more battles will be waged in the court of public opinion – in newspapers, cable news, and online.”

Armentano finishes his statement by saying:

NORML launched the first-ever petition to remove cannabis from Schedule I over 50 years ago. And we are still putting in the work. We are the only cannabis advocacy organization looking out for you – the responsible consumer. And we are the only organization willing to stand toe-to-toe with our political opponents and speak truth to power. Our efforts are changing minds, changing laws, and changing policies. Help ensure our voice is heard.

Thank you for reading The Marijuana Herald! You can find more news stories by clicking here, and you can sign up for daily news updates by clicking here

 

More articles from The Marijuana Herald can be found below.

Public Marijuana Possession and Consumption Would be Downgraded to Civil Violation Under New Delaware Bill

Public Marijuana Possession and Consumption Would be Downgraded to Civil Violation Under New Delaware Bill

Washington, D.C. Medical Marijuana Sales Hit $100.9 Million in 2025 as Patient Count Grows to Nearly 100,000

Washington, D.C. Medical Marijuana Sales Hit $100.9 Million in 2025 as Patient Count Grows to Nearly 100,000

Connecticut Sets New Monthly Marijuana Sales Record in December as Prices Hit All-Time Low

Connecticut Sets New Monthly Marijuana Sales Record in December as Prices Hit All-Time Low

Study: CBD Shows Potent Antibacterial Activity Against Drug-Resistant Enterococcus Strains

Study: CBD Shows Potent Antibacterial Activity Against Drug-Resistant Enterococcus Strains

Study: Hemp Seed Extracts May Enhance Effectiveness of Antibiotics and Antifungal Medications

Study: Hemp Seed Extracts May Enhance Effectiveness of Antibiotics and Antifungal Medications

Study: CBD Gel Reduced Jaw Muscle Activity in Adults With Temporomandibular Disorders

Study: CBD Gel Reduced Jaw Muscle Activity in Adults With Temporomandibular Disorders

Indiana Senate Bill Would Legalize Recreational Marijuana, Including Licensed Sales

Indiana Senate Bill Would Legalize Recreational Marijuana, Including Licensed Sales

Low-Dose CBD Protected Developing Heart From Oxygen-Related Injury in Newborn Animal Study

Low-Dose CBD Protected Developing Heart From Oxygen-Related Injury in Newborn Animal Study

Randomized Controlled Trial Finds CBD May Reduce Anxiety and Perceived Effort in Runners

Randomized Controlled Trial Finds CBD May Reduce Anxiety and Perceived Effort in Runners

Study: Cannabis Extract Triggered Cell Death and Reduced Invasion in Human Breast Cancer Cells

Study: Cannabis Extract Triggered Cell Death and Reduced Invasion in Human Breast Cancer Cells

Vermont Bill Would Require Cities to Vote on Allowing Marijuana Stores During 2026 Election

Vermont Bill Would Require Cities to Vote on Allowing Marijuana Stores During 2026 Election

Tilray Brands Posts Record $217.5M Q2 Revenue

Tilray Brands Posts Record $217.5M Q2 Revenue

Study: CBD Reduced Bladder Pain and Inflammation in Animal Model of Interstitial Cystitis

Study: CBD Reduced Bladder Pain and Inflammation in Animal Model of Interstitial Cystitis

CBD Reduces Bacteria That Causes Gum Disease, Finds New Lab Study

CBD Reduces Bacteria That Causes Gum Disease, Finds New Lab Study

New York Bill Would Give Cannabis Distributors More Time to File Quarterly Tax Returns

New York Bill Would Give Cannabis Distributors More Time to File Quarterly Tax Returns

New Hampshire: Bipartisan Psilocybin Bills Scheduled for Public Hearing on January 14

New Hampshire: Bipartisan Psilocybin Bills Scheduled for Public Hearing on January 14

Maine Marijuana Sales Reach $246 Million in 2025, With 4.8 Million Transactions

Maine Marijuana Sales Reach $246 Million in 2025, With 4.8 Million Transactions

Study: Marijuana Appears in 37% of U.S. Hip-Hop Music Videos

Study: Marijuana Appears in 37% of U.S. Hip-Hop Music Videos